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Abstract: 16 
Atmospheric cold plasma (ACP) is a promising non-thermal technology effective 17 
against a wide range of pathogenic microorganisms. Reactive oxygen species (ROS) 18 
play a crucial inactivation role when air or other oxygen containing gases are used. 19 
With strong oxidative stress, cells can be damaged by lipid peroxidation, enzyme 20 
inactivation and DNA cleavage. Identifying ROS and understanding their role is 21 
important to advance ACP applications to a range of complex microbiological issues. 22 
In this study, the inactivation efficacy of in-package, high voltage (80 kVRMS) ACP 23 
(HVACP) and the role of intracellular ROS were investigated. Two mechanisms of 24 
inactivation were observed where reactive species were found to either react primarily 25 
with the cell envelope or to damage intracellular components. E. coli was inactivated 26 
mainly by cell leakage and low level DNA damage. Conversely, S. aureus was mainly 27 
inactivated by intracellular damage with significantly higher levels of intracellular 28 
ROS observed and little envelope damage. However, for both bacteria studied, 29 
increasing treatment time had a positive effect on intracellular ROS levels generated. 30 
Keywords:   31 
High voltage atmospheric cold plasma, in-package, intracellular ROS, cell leakage, 32 
DNA damage, E. coli and S. aureus  33 
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INTRODUCTION 34 
Atmospheric cold plasma (ACP) refers to non-equilibrium plasma generated at near 35 
ambient temperatures and pressure. They are composed of particles including free 36 
electrons, radicals, positive and negative ions, but are low in collision frequency of 37 
gas discharging compared to equilibrium plasma (1, 2). ACP technologies have been 38 
widely applied for many surface treatments and environmental processes. Recently 39 
they have been studied for food sterilisation and plasma medicine (2-5).  40 
ACP provides inactivation effects against a wide range of microbes, mainly by the 41 
generation of cell-lethal reactive species (6-8). By discharging in air, groups of 42 
reactive species are generated, such as reactive oxygen species (ROS), reactive 43 
nitrogen species (RNS), ultraviolet (UV) radiation, energetic ions and charged 44 
particles (5). However, the inactivation efficacy can be varied by changing the 45 
working gases which results in different types or amounts of reactive species 46 
generated (9-11). ROS are often identified as the principal affecting species with 47 
relatively long half-life and strong anti-microbial effects, which are generated in 48 
oxygen containing gases (12).   49 
ROS generated during plasma discharge in air or oxygen-containing mixtures are 50 
assemblies of ozone, hydrogen peroxide, singlet and atomic oxygen, while ozone is 51 
considered as the most microbicidal specie (13). With strong oxidative stress, cells are 52 
damaged by lipid peroxidation, enzyme inactivation and DNA cleavage. Generating 53 
plasma in air or a nitrogen containing gas mixture can also generate NOx species. 54 
However, a higher inactivation efficacy has been reported with the combined 55 
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application of NO and H2O2 on E. coli than a treatment with NO or H2O2 alone (14). 56 
Reactive nitrogen species are highly toxic and can lead to cell death by increasing 57 
DNA damage (15). One of the potential benefits of ACP as a sterilization or 58 
pasteurization technology is the reported low mutation level associated which may be 59 
attributed to the ‘cocktail’ of reactive species generated (16, 17). However, different 60 
patterns of cellular damage between Gram negative and positive bacteria were 61 
observed in former studies (18, 19). Moreover, the treatment parameter of mode of 62 
exposure has been previously described (13, 20), where the inactivation mechanism 63 
reported was similar in relation to direct or indirect exposure to the plasma. With 64 
regard to inactivation efficacy, indirect exposure to ACP had a reduced microbicidal 65 
effect where interaction with UV, electron beam, charged particles and other 66 
short-lived species was absent. However, the in-package treatment used in this study 67 
allows the contained recombination of reactive radicals, which could result in strong 68 
bactericidal effects, even with indirect exposure. 69 
Thus, the inactivation mechanism of ACP is a possible result of the reactive species 70 
actions, which correlate to process and system parameters. Reactive species reactions 71 
with Gram negative and positive bacteria are potentially different. To prove this 72 
hypothesis, this study compared the inactivation mechanism of HVACP against E. coli 73 
and S. aureus to expand understanding of the possible different patterns of damage 74 
against Gram negative and Gram positive bacteria, especially the action of reactive 75 
oxygen species. The interactive effects of intracellular ROS generation and DNA 76 
damage with treatment time were examined in conjunction with spectral diagnostics 77 
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of the in package process to elucidate the mechanism.   78 
MATERIALS AND METHODS 79 
Bacterial Strains and Growth Conditions 80 
The bacterial strains used in this study were Escherichia coli NCTC 12900 81 
(non-toxigenic O157:H7) and Staphylococcus aureus ATCC 25923. Strains were 82 
chosen to represent both Gram negative and Gram positive bacteria and to facilitate 83 
comparison with other studies. They are pathogens of relevance to the food industry 84 
in addition to their multi-drug resistance and high rate of mutations (21, 22). E. coli 85 
NCTC 12900 was obtained from the National Collection of Type Cultures of the 86 
Health Protection Agency (HPA, UK), and S. aureus was obtained from the 87 
microbiology stock culture of the School of Food Science and Environmental Health, 88 
Dublin Institute of Technology. Strains were maintained as frozen stocks at -70 ºC in 89 
the form of protective beads, which were plated onto tryptic soy agar (TSA, Scharlau 90 
Chemie, Barcelona, Spain) and incubated overnight at 37 ºC to obtain single colonies 91 
before storage at 4 ºC.  92 
Preparation of Bacterial Cell Suspensions 93 
Cells were grown overnight (18 h) by inoculating isolated colonies of respective 94 
bacteria in tryptic soy broth without glucose (TSB-G, Scharlau Chemie, Barcelona, 95 
Spain), at 37 ºC. Cells were harvested by centrifugation at 8,720 g for 10 min. The 96 
cell pellet was washed twice with sterile phosphate buffered saline (PBS, Oxoid LTD, 97 
UK). The pellet was re-suspended in PBS and the bacterial density was determined by 98 
measuring absorbance at 550 nm using McFarland standard (BioMérieux, 99 
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Marcy-l'Étoile, France). Finally, cell suspensions with a concentration of 108 CFU 100 
ml-1 were prepared in PBS.  101 
HVACP system configuration 102 
The dielectric-barrier discharge (DBD) HVACP system used in this study consists of a 103 
high voltage transformer (with input voltage 230 V at 50 Hz), and a voltage variac 104 
(output voltage controlled within 0~120 kV) (Figure 1). HVACP discharge was 105 
generated between two 15-cm diameter aluminium electrodes separated by two 106 
perspex dielectric layers (10 mm and 1mm thickness). The system was operated at 107 
high voltage level of 80 kVRMS at atmospheric pressure. Voltage and input current 108 
characteristics of the system were monitored using an InfiniVision 2000 X-Series 109 
Oscilloscope (Agilent Technologies Inc., USA). A polypropylene container, which 110 
acted as both a sample holder and an additional dielectric barrier, was placed between 111 
the two perspex dielectric layers. The distance between the two electrodes was kept 112 
constant (2.2 cm) for all experiments.  113 
HVACP treatment 114 
For direct plasma treatment, 10 ml of bacterial cell suspensions in PBS were 115 
aseptically transferred to a sterile plastic petri dish, which was placed in the centre of 116 
the polypropylene container, between the electrodes. For indirect plasma treatment, a 117 
separate container was used, where the sample petri dish was placed on the upper left 118 
corner of the container, outside the plasma discharging area. Each container was 119 
sealed in a high barrier polypropylene bag (B2630; Cryovac Sealed Air Ltd, Dunkan, 120 
SC, USA) using atmospheric air as a working gas for HVACP generation. Bacterial 121 
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samples were then treated with HVACP at 80 kVRMS for 1, 3 and 5 min. After HVACP 122 
treatment, samples were subsequently stored at room temperature for either 0, 1 or 24 123 
h (23). Ozone concentrations were measured using GASTEC gas tube detectors 124 
(Product # 18M, Gastec Corporation, Kanagawa, Japan) immediately after treatment 125 
and also after 1 or 24 h storage. Containers were kept sealed to ensure the retention of 126 
contact with generated reactive species during post-treatment storage. Microbiological 127 
analysis were immediately applied after respective post-treatment storage. All 128 
experiments were carried out in duplicate and replicated twice. 129 
Microbiological Analysis 130 
To quantify the effects of plasma treatment, 1 ml of treated samples were serially 131 
diluted in maximum recovery diluent (MRD, Scharlau Chemie, Barcelona, Spain) and 132 
0.1 ml aliquots of appropriate dilutions were surface plated on TSA. 1 ml and 0.1 ml 133 
of the treated sample was spread onto TSA plates as described by EN ISO 11290-2 134 
method (ISO 11290-2, 1998). The limit of detection was 1 Log CFU ml−1. Plates were 135 
incubated at 37 ºC for 24 h and colony forming units were counted. Any plates with 136 
no growth were incubated for up to 72 h and checked for the presence of colonies 137 
every 24 h. Results are reported in Log CFU ml−1 units. 138 
Detection of reactive oxygen species after plasma treatment 139 
DCFH (2',7'-dichlorodihydrofluorescein) is a cellular assay probe widely used for 140 
fluorescence detection of intracellular ROS. It revealed the concentration of ROS in 141 
HVACP treated samples. 142 
After HVACP treatment and subsequent storage, cells were incubated with DCFH-DA 143 
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(2',7'-dichlorodihydrofluorescein diacetate, Sigma Aldrich Ltd, Dublin, Ireland) at a 144 
final concentration of 5 μM in PBS for 15 min at 37 °C. Two hundred µL aliquots of 145 
each sample were transferred into 96 well fluorescence microplate wells (Fisher 146 
Scientific, UK) and measured by SynergyTM HT Multi-Mode Microplate Reader 147 
(BioTek Instruments Inc.) at excitation and emission wave lengths of 485 and 525 nm.  148 
Optical emission spectroscopy 149 
Optical emission spectroscopy (OES) of the discharge within empty packages was 150 
acquired with an Edmund Optics UV Enhanced Smart CCD Spectrometer with an 151 
optical fibre input. UV Enhanced Smart CCD Spectrometers have been optimized for 152 
maximum performance in the ultraviolet and near UV region, and for multichannel 153 
operation with ultra-low trigger delay.  The spectral resolution of the system was 0.6 154 
nm. 155 
The fibre optic from the spectrometer was placed facing towards the package to allow 156 
the light to cross the centre of the side wall of the polypropylene container. The fibre 157 
had a numerical aperture of 0.22 mm and was optimized for use in the ultraviolet, 158 
visible and near infrared portion of the spectrum with a wavelength range of 200–159 
920 nm. A 5 mm diameter lens collected light from a column across the diameter of 160 
the package and focused it onto a 200 μm multi-mode fibre. The other end of the 2 m 161 
long fibre was connected to the spectrometer. 162 
Cell membrane integrity 163 
Membrane integrity was examined by determination of the release of intracellular 164 
materials absorbing at 260 and 280 nm (A260 and A280) (24). Untreated (bacterial cells 165 
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in PBS) and HVACP-treated samples were centrifuged at 13,200 g for 10 min. 166 
Untreated controls were used to determine the release of any intracellular material 167 
before HVACP treatment. Two hundred µL supernatant of each sample was 168 
transferred into UV-transparent microtitre plate (Corning Life Science, US) wells and 169 
measured by SynergyTM HT Multi-Mode Microplate Reader at 260 nm and 280 nm. 170 
DNA damage 171 
To further examine intracellular damage, double-strand DNA (dsDNA) concentrations 172 
were investigated after 24 h storage, which provided adequate reaction time between 173 
ROS and cell components. SYBR Green I, 174 
[2-[N-(3-dimethylaminopropyl)-N-propylamino]-4-[2,3-dihydro-3-methyl-(benzo-1,3175 
-thiazol-2-yl)-methylidene]-1-phenyl-quinolinium], is a highly sensitive detector of 176 
dsDNA and can be used to quantify nucleic acids. SYBR Green I has been widely 177 
used in fluorescence analysis, real-time PCR and biochip applications. (25) In this 178 
study, it was used as an indicator of DNA damage with a digested cell solution. 179 
Lysozyme and lysostaphin hydrolyse the bacterial cell wall by breaking 1-4 bonds 180 
between N-acetyl-β-D-glucosamine (NAG), N-acetyl-β-D-muramic acid (NAM) and 181 
polyglycine cross-links present in the peptidoglycan (26).  182 
Following HVACP treatment E. coli samples were incubated with 100 µg mL-1 183 
lysozyme at 37 oC for 4 h to break the cell envelope and release the intracellular DNA. 184 
Because of the different cellular structures in Gram positive bacteria, S. aureus 185 
samples were incubated with 100 µg mL-1 lysozyme and 10 µg mL-1 lysostaphin at 37 186 
oC for 4 h. Cell digestion effects were verified by colony counts on TSA plates. Cells 187 
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without HVACP treatment were digested and used as positive control group, while 188 
untreated cells without digestion were used as negative controls. The bacterial 189 
envelope was considered as completely digested when the survival rate was below the 190 
detection level. 191 
After cell digestion, solutions were incubated with SYBR Green I (1:10,000, Sigma 192 
Aldrich Ltd, Dublin, Ireland) at working concentration (1:1) for 15 min at 37 °C. 200 193 
µL aliquots of each sample were transferred into 96 well fluorescence microplate 194 
wells (Fisher Scientific, UK) and measured by SynergyTM HT Multi-Mode Microplate 195 
Reader at excitation and emission wave lengths of 485 and 525 nm. 196 
Scanning Electron Microscopy 197 
Bacterial samples in PBS exposed to plasma for 1 min treatment with a post-treatment 198 
storage time of 1 or 24 h were selected for SEM analysis. This was based on a 199 
noticeable difference in plasma inactivation efficacy with respect to post-treatment 200 
storage time. Bacterial cells were prepared as described by Thanomsub et al. 2002 201 
with minor modifications (27, 28). Samples were then examined visually by using a 202 
FEI Quanta 3D FEG Dual Beam SEM (FEI Ltd, Hillsboro, USA) at 5 kV. 203 
Statistical Analysis 204 
Statistical analysis was performed using SPSS 22.0 (SPSS Inc., Chicago, U.S.A.). 205 
Data represent the means of experiments performed in duplicate and replicated at least 206 
twice. Means were compared using analysis of variance (ANOVA) using Fisher’s 207 
Least Significant Difference-LSD at the 0.05 level. 208 
 209 
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RESULTS 210 
Effect of treatment time and post-storage time on plasma inactivation efficacy 211 
The inactivation efficacy of HVACP against E. coli NCTC 12900 and S. aureus ATCC 212 
25923 is shown in Tables 1 and 2. Inactivation was related to both treatment time and 213 
post-treatment storage time.  214 
After 1 min exposure of HVACP, E. coli samples were decreased by around 2 log 215 
cycles in conjunction with 24 h post treatment storage. When treatment time was 216 
increased to 3 min, bacterial populations were undetectable for both 1 and 24 h 217 
storage times. Without post-treatment storage, approximately 3.6 and 2.3 log cycle 218 
reductions were detected with direct and indirect exposure after 3 min treatment, but 219 
further extending treatment time to 5 min resulted in 6 log cycle and at least 8 log 220 
cycle reductions for direct and indirect exposure respectively (Table 1, p≤0.05). 221 
A similar trend of HVACP inactivation was recorded for S. aureus. With 24 h storage, 222 
all treatment times used led to undetectable levels of bacterial population, irrespective 223 
of the mode of exposure. Increasing treatment time, from 1 min to either 3 or 5 min, 224 
yielded undetectable levels, with direct and indirect exposure, respectively, after 1 h 225 
storage. With no post treatment storage time, populations declined by approximately 226 
1.8 and 6.1 log cycles by increasing treatment time from 1 min to 5 min with direct 227 
exposure (Table 2, p≤0.05). Similar effects were achieved with indirect exposure. 228 
Effect on cell membrane integrity 229 
The absorbance of 260 and 280 nm which is commonly used for quantification of 230 
DNA and protein concentration, can also indicate the release of intracellular DNA and 231 
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protein and loss of cell integrity (24). Different trends between E. coli and S. aureus 232 
were observed from their absorbance measured at 260 nm following plasma treatment 233 
(Figure 2 and 3).  234 
For E. coli, all absorption curves showed similar trends (Figure 2). With 24 h 235 
post-treatment storage, a sharp increase in absorbance followed by a steady stage 236 
indicated that the cell integrity was compromised within 1 min of HVACP treatment. 237 
In the case of 0 and 1 h post treatment storage samples, a sharp increase at 1 min of 238 
treatment was followed by a gradual increase in the absorbance as a function of 239 
treatment time (p≤0.05). In contrast, no leakage was recorded for S. aureus, even 240 
after 5 min treatment (Figure 3, p>0.05). However, a small increase in absorbance was 241 
observed for the 24 h post treatment storage sample group for both control and treated 242 
samples. Similar trends were observed at 280 nm (data not shown).  243 
Reactive oxygen and nitrogen species 244 
The emission spectrum is presented in Figure 4 (a). Analysis of the discharge was 245 
carried out in air at 80 kVRMS over the range of 200 - 920 nm. Distinct peaks obtained 246 
in the near UV and visible regions corresponded to strong emissions from N2 and N
+
2 247 
excited species. The ozone concentration inside package after HVACP treatment was 248 
investigated using colorimetric tubes, which revealed its correlation with treatment 249 
and post-treatment storage time (Table 3). The in-package ozone densities were 250 
similar for each bacterial sample. Treatment time and post-treatment storage time had 251 
positive and negative effects respectively on the ozone concentration detected. 252 
Detected ozone concentration were not significantly different from containers of E. 253 
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coli or S. aureus samples with same treatment parameters. No ozone was detected in 254 
either treatment condition after the 24 h post-treatment storage time. In air 255 
DBD-ACPs, the well-known generation–depletion cycle of ozone is interlinked to that 256 
of nitrogen oxides through several gas-phase reactions that generate N2O, NO and O 257 
atoms starting from O2 and N
∗
2 (29). In Figure 4 (b), one of the major emission 258 
intensity of second positive N2 system from empty box and sample packages, where 259 
other major peaks had similar results (data not shown). 260 
The concentrations of ozone and nitrogen oxides (O3, NO2, NO3, N2O4) for this set-up 261 
were quantified using absorption spectroscopy (OAS) and are reported elsewhere (29). 262 
The measurements of ozone using the gas detectors compare with those reported 263 
using OAS. 264 
The oxidant-sensing fluorescent probe, DCFH-DA, is a nonpolar dye, which is 265 
converted into the nonfluorescent polar derivative DCFH by cellular esterases and 266 
switched to highly fluorescent DCF when oxidized by intracellular ROS and other 267 
peroxides (30). It has been widely used for intracellular detection with fluorescence 268 
analysis. The fluorescence signal correlated with the intracellular ROS density. Figure 269 
5 shows the intracellular ROS density results of E. coli and S. aureus in PBS, where a 270 
similar trend of ROS generation in response to HVACP is demonstrated for both 271 
bacteria. With regard to the effect of mode of exposure, with indirect treatment the 272 
ROS density increased gradually as a function of treatment time from 1 min to 5 min, 273 
by comparison with direct treatment where ROS density was lower with prolonged 274 
treatment. 275 
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DNA damage 276 
Figure 6 presents the dsDNA quantity of E. coli and S. aureus before and after 277 
HVACP treatment. The control group from both bacteria obtained similar signal 278 
strength, which proved a similar initial DNA amount from samples. However, 279 
different signal levels were observed from the two treated strains. E. coli samples 280 
showed a reduction of fluorescence signal which correlated with treatment time. 281 
However, there was only a trace of fluorescence signal from S. aureus samples after 282 
treatment (p≤0.05). 283 
Scanning Electron Microscopy 284 
From the SEM results (Figure 7), more visible damage was evident on E. coli surfaces 285 
than S. aureus, indicating cell breakage effects for E. coli inactivation, while HVACP 286 
treatment caused irregular shape and cell shrinkage in S. aureus.  287 
Proposed Inactivation Mechanism 288 
Figure 8 illustrates the proposed mechanism of action of ACP with Gram negative and 289 
Gram positive bacteria based on the results described here for E. coli and S. aureus. 290 
After HVACP treatment, generated reactive oxygen species, associated with process 291 
and system parameters, attack both cell envelope and intracellular components. For 292 
Gram negative cells the cell envelope is the major target of ROS. Reactions of ROS 293 
with cell components cause disruption of the cell envelope and result in leakage, with 294 
some possible damage of intracellular components (eg. DNA). For Gram positive 295 
cells the intracellular components are the major target of ROS. Reactions of ROS will 296 
cause severe damage of intracellular components (eg. DNA), but not cell leakage. 297 
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Lower intracellular ROS in Gram negative bacteria can be result of both ROS 298 
depletion by cell envelope components and the cell leakage. 299 
 300 
DISCUSSION 301 
From the results of inactivation efficacy, there is clearly a strong effect of increasing 302 
treatment time, even without post treatment storage time. However, a surviving 303 
population could be below the detection limit with recovery possible during storage 304 
under some treatment and storage conditions. No further enrichment procedures were 305 
employed in this study. Incorporating a post-treatment storage time increased the 306 
inactivation efficacy significantly, especially with 24 h post-treatment storage time, 307 
which could be attributed to the amount of reactive species generated and their 308 
extended reaction time with bacteria (Tables 1 and 2). Similar results have been 309 
observed in our former studies (18). A post treatment storage time with retained 310 
antimicrobial efficacy has two-fold potential advantage, whereby the initial exposure 311 
could be minimal with enhanced efficacy during storage which is compatible with 312 
treatment of sensitive samples. Additionally a post treatment storage stage is 313 
compatible with many industrial processes. However, with applications to the food, 314 
beverage and pharmaceutical industries in mind, the strong oxidative effect with long 315 
HVACP exposure time could adversely affect some ingredients by inducing surface 316 
oxidation, which has been observed from ozone food sterilization technologies (31). A 317 
challenge for developing HVACP applications in the food industry is to optimize the 318 
dose or gas mixtures applied to ensure control of microbiological risks whilst 319 
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maintaining food quality characteristics. 320 
A hypothetic mechanism of action of HVACP against E. coli and S. aureus were 321 
concluded as shown in Figure 8. Different reaction mechanism with ROS and cell 322 
components are discussed below from reactive species and cell damage results. 323 
The leakage studies recorded pointed to different modes of action. High leakage levels 324 
were observed with all treatment and post-treatment storage steps for E. coli (p≤0.05), 325 
but not in S. aureus (p>0.05) (Figure 2 and 3). The cell wall of Gram positive bacteria 326 
consists of peptidoglycan with tight structure and strength, while Gram negative 327 
bacteria are covered by a thin layer of peptidoglycan and an outer membrane of 328 
lipopolysaccharide. During plasma treatment, generated ROS can react with both 329 
lipopolysaccharide and peptidoglycan thus breaking the molecule structure by 330 
damaging C-O, C-N and C-C bonds. (32-34) However, an obvious leakage was only 331 
observed from E. coli. With the higher lipid content, lipid peroxidation may have 332 
taken place on lipopolysaccharides and resulted in the breakage of the cell envelope. 333 
(19) This could suggest that reactive species reacted with the cell wall in different 334 
patterns. Reactions with other cell wall components, such as peptidoglycan, could be 335 
also involved. Furthermore, Figure 7 visually illustrates the difference between E. coli 336 
and S. aureus after HVACP treatment and further supports our hypothesis on the 337 
pattern of damage. The effect of shrinkage but not breakage has also been reported on 338 
another Gram positive bacteria, L. monocytogenes (35).  339 
As a main inactivation species, the ozone level inside the package showed strong 340 
correlation with treatment time and post-treatment storage time, but not with the type 341 
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of bacteria in the sample (Table 3). However, the fluorescent signal recorded for S. 342 
aureus was three times that of E. coli, thus indicating a much higher intracellular ROS 343 
density in S. aureus than for E. coli (Figure 5, p≤0.05). A similar time correlated ROS 344 
generation was reported by other researchers using a plasma jet treatment. 345 
Intracellular ROS increased over 5 min of treatment by air plasma from a jet (36), 346 
with a similar trend reported on generation of RNS (37). Plasma treatment time 347 
determines the input energy during discharging. As the key reactive species for 348 
oxygen containing working gases, the generation of ROS consumes most of the 349 
energy in air plasma. It has been suggested that in-package ROS can penetrate cell 350 
membranes by active transport across the lipid bilayer or transient opening of pores in 351 
the membrane (3). This could explain the correlation between treatment time and 352 
ozone/ intracellular ROS. The mode of exposure also adds complexity, where an 353 
obvious difference in reactive species was observed from OES and DCFH DA assay 354 
according to mode of exposure (Figure 4 and 5). Lower reactive species levels were 355 
detected from samples exposed to direct plasma than the indirectly exposed samples. 356 
This could be due to the quenching effect of liquid between electrodes on the ionizing 357 
of gases. However, similar inactivation levels and cell components damage were 358 
recorded. During direct treatment, undetectable ROS, mostly very short lived and 359 
transient species, might react immediately with cell components and be transformed. 360 
It appears cells were damaged by the relatively long lived species associated with 361 
indirect treatment, such as higher ozone levels. 362 
After plasma discharging, the ozone concentrations in the gas phase were determined 363 
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to be independent of the type of bacteria, while intracellular ROS levels were strongly 364 
correlated with both process parameter and target bacteria characteristic. This could 365 
contribute to the different reaction and diffusion patterns of ROS to the cells. Based 366 
on the absorbance results at 260 nm in Figure 2 and 3, HVACP generated ROS could 367 
react with the cell wall rather than entering the cell in E. coli samples, whilst ROS 368 
accumulated inside the S. aureus cells. 369 
E. coli samples showed a reduction of fluorescence signal of DNA correlating with 370 
treatment time in Figure 6. This trend elucidated that DNA damage has a plasma dose 371 
dependent pattern. There was only a trace of fluorescence signal from S. aureus 372 
samples post treatment, indicating greater DNA damage than with E. coli. It has been 373 
reported that plasma induced oxidative stress damage in S. aureus is due to 374 
intracellular oxidative reactions (38). 375 
Overall, treatment time and post-treatment storage time had strong effects on 376 
inactivation efficacy against E. coli and S. aureus in this study, with a lower impact 377 
observed for mode of plasma exposure. The amount of reactive species generated, 378 
including ozone, has been correlated with inactivation efficacy (12, 36, 39-41). 379 
Among the reactive species generated during HVACP treatment, ROS contributed as 380 
major antimicrobial factors. Their concentrations were governed by plasma dose and 381 
applied gas compositions (18). The generation of ozone as an indicator of ROS 382 
showed a time-dependent pattern, while intracellular ROS had a similar trend. During 383 
penetration, ROS could react with the lipid content in the cell membrane and cause 384 
certain damage. Compared with Gram positive bacteria, the membrane of Gram 385 
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negative bacteria was more vulnerable. Visible damage as a result of plasma exposure 386 
was previously observed for E. coli (13). 387 
A much higher intracellular ROS density detected in S. aureus showed the probable 388 
penetration of reactive species within the cell. At the same time, higher concentrations 389 
of reactive species overall could lead to more intracellular damage to cell components 390 
such as DNA, which was clearly noted in this study. Since the total amount of ROS 391 
generated using any system or process setting is around the same level and is 392 
independent of the target bacteria characteristics, it is apparent that less cell envelope 393 
damage may be associated with more intracellular damage.  394 
In this study, the HVACP inactivation efficacy of E. coli and S. aureus bacteria was 395 
correlated with process and system parameters (i.e. treatment time or post-treatment 396 
storage time). These determined the amount and reaction time of reactive species, 397 
which were the essential factors of antimicrobial reactions. Two different possible 398 
mechanisms of inactivation were observed in the selected Gram negative and Gram 399 
positive bacteria. Reactive species were either reacting with cell envelope or 400 
damaging intracellular components. E. coli was inactivated by cell envelope damage 401 
induced leakage, while S. aureus was mainly eliminated by intracellular damage. 402 
Additionally, the different cell damage mechanisms might due to different type of 403 
reactive species with regard to the mode of exposure. These findings are critical for 404 
the successful development of plasma applications where the system and process 405 
parameters can be nuanced in relation to the target risk characteristics presented.  406 
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Tables and Figures 545 
Table 1. Surviving cell numbers of E. coli NCTC 12900 with respect to treatment and 546 
post-treatment storage time 547 
Post-treatment 
storage time 
(h) 
Plasma 
treatment 
time 
(min) 
Mode of Plasma Exposure 
Direct Indirect 
Cell 
density 
(Log10 
CFU/ml) 
SD* 
Cell 
density 
(Log10 
CFU/ml) 
SD* 
0 
0 8.0a 0.0 8.0a 0.0 
1 7.6a 0.1 7.3b 0.1 
3 4.3b 0.1 5.7c 0.1 
5 2.1c 0.7 ND*d 0.0 
1 
0 8.0a 0.0 8.0a 0.0 
1 7.2d 0.1 7.1b 0.2 
3 NDe 0.0 NDd 0.0 
5 NDe 0.0 NDd 0.0 
24 
0 8.0a 0.0 8.0a 0.0 
1 5.9df 0.1 6.1be 0.8 
3 NDe 0.0 NDd 0.0 
5 NDe 0.0 NDd 0.0 
Different letters indicate a significant difference at the 0.05 level between different 548 
treatment times and post-treatment storage times 549 
Critical controls were provided as 0 min treated samples with 0, 1 and 24 h 550 
post-treatment storage. 551 
SD*: Standard deviation 552 
ND*: Under detection limit   553 
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Table 2. Surviving cell numbers of S. aureus ATCC 25923 with respect to treatment 554 
and post-treatment storage time 555 
Post-treatment 
storage time 
(h) 
Plasma 
treatment 
time 
(min) 
Mode of Plasma Exposure 
Direct Indirect 
Cell 
density 
(Log10 
CFU/ml) 
SD* 
Cell 
density 
(Log10 
CFU/ml) 
SD* 
0 
0 7.9a 0.2 7.9a 0.2 
1 6.1b 0.3 5.8b 0.3 
3 5.4c 0.6 5.3c 0.1 
5 1.8d 0.2 1.7d 0.1 
1 
0 7.8a 0.2 7.8a 0.2 
1 4.3bf 0.0 2.0bf 0.0 
3 NDe 0.0 NDe 0.0 
5 NDe 0.0 NDe 0.0 
24 
0 7.8a 0.2 7.8a 0.2 
1 NDe 0.0 NDe 0.0 
3 NDe 0.0 NDe 0.0 
5 NDe 0.0 NDe 0.0 
Different letters indicate a significant difference at the 0.05 level between different 556 
treatment times and post-treatment storage times 557 
Critical controls were provided as 0 min treated samples with 0, 1 and 24 h 558 
post-treatment storage. 559 
SD*: Standard deviation  560 
ND*: Under detection limit  561 
562 
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Table 3. In-package ozone concentration after different HVACP treatment and 563 
post-treatment storage time with both E. coli and S. aureus samples 564 
Post-treatment 
storage time 
(h) 
Plasma 
treatment 
time 
(min) 
Ozone concentration (ppm) 
 
Direct Indirect 
0 
1 1600 1800 
3 2400 3000 
5 4200 4400 
1 
1 100 120 
3 180 190 
5 330 350 
24 
1 ND ND 
3 ND ND 
5 ND ND 
ND*: Non-detectable  565 
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 566 
Figure 1. A schematic diagram of the DIT120+ HVACP device.  567 
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 568 
Figure 2. Absorbance of HVACP treated E. coli NCTC 12900 suspension in PBS at 569 
260 nm with different post-treatment storage times 570 
Data points at 0 min treatment time refer to untreated control stored with 0, 1, 24 h in 571 
PBS 572 
1, 3, 5 min treatment at 80 kVRMS with 0, 1, 24 h post-treatment storage 573 
(■ 0 h post-treatment storage time; ♦ 1 h post-treatment storage time; ▲ 24 h 574 
post-treatment storage time) 575 
(Solid line: direct exposure; Dotted line: indirect exposure)  576 
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 577 
Figure 3. S. aureus ATCC 25923 absorbance at 260 nm after HVACP treatment in 578 
PBS 579 
Data points at 0 min treatment time refer to untreated control stored with 0, 1, 24 h in 580 
PBS 581 
1, 3, 5 min treatment at 80 kVRMS with 0, 1, 24 h post-treatment storage 582 
(■ 0 h post-treatment storage time; ♦ 1 h post-treatment storage time; ▲ 24 h 583 
post-treatment storage time) 584 
(Solid line: direct exposure; Dotted line: indirect exposure)  585 
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 586 
Figure 4. Emission spectrum of dielectric barrier discharge atmospheric cold plasma 587 
operating in air under atmospheric pressure 588 
(a) Emission spectrum of empty box 589 
(b) Emission intensity at 336.65 nm (■ Empty box; ▲ Direct exposure; ♦ Indirect 590 
exposure.)  591 
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 592 
 593 
Figure 5. E. coli NCTC 12900 and S. aureus ATCC 25923 Intracellular ROS density 594 
assay by DCFH DA 595 
1, 3, 5 min treatment at 80 kVRMS with 0 h post-treatment storage 596 
(  E. coli NCTC 12900;  S. aureus ATCC 25923) 597 
* indicate a significant difference at the 0.05 level between E. coli and S. aureus  598 
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 599 
Figure 6. E. coli NCTC 12900 and S. aureus ATCC 25923 DNA quantification assay 600 
by SYBR Green 1 601 
1, 3, 5 min treatment at 80 kVRMS with 24 h post-treatment storage 602 
(  E. coli NCTC 12900;  S. aureus ATCC 25923) 603 
* indicate a significant difference at the 0.05 level between E. coli and S. aureus   604 
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 605 
Figure 7. SEM images of control and treated cells with 80 kVRMS 1 min indirect 606 
plasma exposed following 24 h post-treatment storage 607 
(a) Untreated S. aureus ATCC 25923  608 
(b) Treated S. aureus ATCC 25923 609 
(c) Untreated E. coli NCTC 12900  610 
(d) Treated E. coli NCTC 12900  611 
  612 
(b) 
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 613 
Figure 8. Proposed mechanism of action of HVACP with Gram negative and positive 614 
bacteria  615 
a, b, c the proposed inactivation mechanism of Gram negative bacteria: a, structure of 616 
Gram negative bacteria before treatment, cell envelope consists of thin layer of 617 
peptidoglycan and lipopolysaccharide; b, ACP generated ROS attacking both cell 618 
envelope and intracellular components, where cell envelope is the major target; c, 619 
inactivation mainly caused by cell leakage, with some DNA damage possible.  620 
c, d, e the proposed inactivation mechanism of Gram positive bacteria: c, structure of 621 
Gram positive bacteria before treatment, cell envelope consist a thick rigid layer of 622 
peptidoglycan; d, ACP generated ROS attacking both cell envelope and intracellular 623 
components, where intracellular materials are the major targets; e, inactivation mainly 624 
caused by intracellular damage (eg. DNA breakage), but not leakage.  625 
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